StreetInsider.com News Articles

Form 8-K CLEARONE INC For: Jul 06

Mon, 06 Jul 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260706/26735997.html

Form 8-K CLEARONE INC For: Jul 06

Mon, 06 Jul 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260706/26735997.html

ClearOne to acquire Cortigent in merger deal, plans $10M-$15M raise

Thu, 02 Jul 2026 08:02:10 -0400

ClearOne, Inc. (Nasdaq: CLRO) has entered into a definitive merger agreement to acquire Cortigent, Inc., a wholly-owned subsidiary of Vivani Medical, Inc. (Nasdaq: VANI), according to a press release from the company.

Under the terms of the agreement, Cortigent will become a wholly-owned subsidiary of ClearOne. As consideration, Vivani will receive 12,500,000 shares of ClearOne common stock. Upon closing, Vivani is expected to own between 59.4% and 67.5% of the combined company, while existing ClearOne shareholders would own between 12.7% and 14.4%.

ClearOne has agreed to file a registration statement on Form S-1 to raise a minimum of $10,000,000 and a maximum

ClearOne to acquire Cortigent in merger deal, plans $10M-$15M raise

Thu, 02 Jul 2026 08:02:10 -0400

ClearOne has agreed to file a registration statement on Form S-1 to raise a minimum of $10,000,000 and a maximum

ClearOne to acquire Cortigent in merger deal, plans $10M-$15M raise

Thu, 02 Jul 2026 08:02:10 -0400

ClearOne has agreed to file a registration statement on Form S-1 to raise a minimum of $10,000,000 and a maximum

ClearOne to acquire Cortigent in merger deal, plans $10M-$15M raise

Thu, 02 Jul 2026 08:02:10 -0400

ClearOne has agreed to file a registration statement on Form S-1 to raise a minimum of $10,000,000 and a maximum

ClearOne to acquire Cortigent in merger deal, plans $10M-$15M raise

Thu, 02 Jul 2026 08:02:10 -0400

ClearOne has agreed to file a registration statement on Form S-1 to raise a minimum of $10,000,000 and a maximum

ClearOne to acquire Cortigent in merger deal, plans $10M-$15M raise

Thu, 02 Jul 2026 08:02:10 -0400

ClearOne has agreed to file a registration statement on Form S-1 to raise a minimum of $10,000,000 and a maximum

ClearOne to acquire Cortigent in merger deal, plans $10M-$15M raise

Thu, 02 Jul 2026 08:02:10 -0400

ClearOne has agreed to file a registration statement on Form S-1 to raise a minimum of $10,000,000 and a maximum

ClearOne to acquire Cortigent in merger deal, plans $10M-$15M raise

Thu, 02 Jul 2026 08:02:10 -0400

ClearOne has agreed to file a registration statement on Form S-1 to raise a minimum of $10,000,000 and a maximum

ClearOne to acquire Cortigent in merger deal, plans $10M-$15M raise

Thu, 02 Jul 2026 08:02:10 -0400

ClearOne has agreed to file a registration statement on Form S-1 to raise a minimum of $10,000,000 and a maximum

ClearOne to acquire Cortigent in merger deal, plans $10M-$15M raise

Thu, 02 Jul 2026 08:02:10 -0400

ClearOne has agreed to file a registration statement on Form S-1 to raise a minimum of $10,000,000 and a maximum

Vivani to merge Cortigent unit with ClearOne in Nasdaq deal

Thu, 02 Jul 2026 08:01:09 -0400

Vivani Medical, Inc. (NASDAQ: VANI) has entered into a definitive merger agreement to combine its wholly owned subsidiary Cortigent, Inc. with ClearOne, Inc. (NASDAQ: CLRO), a Nasdaq-listed company, according to a statement released July 2, 2026.

Under the terms of the agreement, Cortigent will merge with a wholly owned subsidiary of ClearOne, making Cortigent a wholly owned subsidiary of ClearOne upon closing. Vivani will receive 12,500,000 shares of ClearOne common stock as consideration and is expected to own between 59.4% and 67.5% of the combined company. Former ClearOne shareholders are expected to hold between 12.7% and 14.4% of the combined entity.

ClearOne

Vivani to merge Cortigent unit with ClearOne in Nasdaq deal

Thu, 02 Jul 2026 08:01:09 -0400

ClearOne

ClearOne Announces Entry into Merger Agreement with Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani Medical